Total Funding
9
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
298553
TherOx is a medical device company dedicated to elevate the standard of care for heart attack patients.
Acquired by 
ZOLL Medical Corporation
Kevin T. Larkin: President & CEO & Board of DirectorsPast Role: Ventritex, Vice President, Marketing and Sales- J. Richard Spears: Co-Founder
About the Company
TherOx operates as a private venture-financed medical device company based in Irvine, California. It is dedicated to elevating the standard of care for the treatment of heart attack patients. Its proprietary technology has been developed and iterated over a number of years and has been thoroughly studied in benchtop studies, animal studies, and
clinical trials. Beyond the initial treatment of heart attack with SuperSaturated Oxygen Therapy (SSO2), TherOx has identified applications for SSO2 in stroke, oncology, and wound care. The Company currently holds 20 issued patents with additional applications pending.
